文拉法辛治疗广泛性焦虑症

Venlafaxine in treatment of generalized anxiety disorder

目的 :观察文拉法辛治疗广泛性焦虑症的临床疗效及不良反应。方法 :根据CCMD Ⅱ R诊断为广泛性焦虑症的 2 1例病人 ,男性 13例 ,女性 8例 ,年龄 33a±s 16a( 18～ 65a) ,病程 14mo± 12mo( 1～ 60mo) ,给文拉法辛 50mg·d- 1,po× 4wk。治疗前后每周进行HAMA ,TESS评定及常规的实验室检查。结论 :文拉法辛抗焦虑作用 ,1wk见效 ,4wk显效率达 76%。不良反应以口干、出汗、恶心、头痛等多见。结果 :文拉法辛治疗广泛性焦虑症疗效确切 。

AIM: To study the efficacy and adverse reactions of venlafaxine in the treatment of generalized anxiety disorder. METHODS: Twenty one patients (M 13, F 8; age 33 a± s 16 a) with diagnosis of generalized anxiety disorder according to CCMD Ⅱ R were treated with venlafaxine 50 mg·d -1 for 4 wk. Patients were assessed with the HAMA and TESS and routine experimental examination before and after treatment. RESULTS: Venlafaxine was obvious effective to generalized anxiety disorder. The effectiveness appeared after 1 wk. The remarkable effective rate was 76% at 4 wk. The main adverse reactions of venlafaxine were thirst, sweating nausea and headache etc. CONCLUSION: Venlafaxine is an effective and safe drug in the treatment of generalized anxiety disorder.